Clinical Trial Update: A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants

View source ↗

Summary

A real-world observational study led by Novo Nordisk A/S to assess cardiovascular risk profiles in people newly diagnosed with Type 2 diabetes mellitus. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Status: RECRUITING